Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01535066 · ClinicalTrials.gov registry record · NA
S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer
A NA study, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- NA
- Development phase
- 226
- Enrollment target
NCT01535066 is a NA study that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 226 participants.
The verdict
NCT01535066, a NA study, has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 226 participants
- Enrollment target
Study Summary
RATIONALE: Acupuncture may help relieve joint pain. PURPOSE: This randomized phase III trial studies acupuncture to see how well it works compared to sham acupuncture or waitlist in treating patients with joint pain related to aromatase inhibitors in patients with early-stage breast cancer.
Interventions
- PROCEDURE acupuncture therapy
- PROCEDURE sham acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2012-05-16 |
| Est. Completion | 2018-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01535066
The ClinicalTrials.gov registry entry for NCT01535066 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which acupuncture therapy is the first listed.
NCT01535066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01535066 about?
NCT01535066 is a clinical study titled "S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer". RATIONALE: Acupuncture may help relieve joint pain. PURPOSE: This randomized phase III trial studies acupuncture to see how well it works compared to sham acupuncture or waitlist in treating patients with joint pain related to aromatase inhibitors in patients with early-stage breast cancer.
What is the current status of trial NCT01535066?
This trial is currently completed. It is a NA study. The enrollment target is 226 participants. The study started on 2012-05-16. Estimated completion is 2018-07-01.
What interventions are being tested in trial NCT01535066?
The interventions under investigation include: acupuncture therapy (PROCEDURE), sham acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT01535066?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.